Wintner LM, Sztankay M, Abdel-Razeq H, et al. Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial. Lancet Oncol 2026; 27: 233–42—In this Article, the final sentence in the Findings of the Summary should have read “There was no significant difference for pain, diarrhoea, fatigue, and peripheral sensory neuropathy.” In the figure, the box noting exclusions from the intervention group should have read “28 had incomplete CTCAE assessments”.
The Lancet Oncology published a clinical update in Oncology on 01 Apr 2026.
The item focuses on Correction to Lancet Oncol 2026; 27: 233–42.
Review the original article for the full source wording and details.